Skip to content. | Skip to navigation

Personal tools
Log in
You are here: Home Know-who Know-how Directory From A to Z BioPartner Start-up Ventures

BioPartner Start-up Ventures

Business focus: Life Sciences Investment Fund.


BioPartner

       

BioPartner Start-up Ventures
Dalsteindreef 25-27
1112 XC Diemen
Website BioPartner Start-up Ventures
E-mail BioPartner Start-up Ventures
T +31 (0)20 750 20 00

Employees in Amsterdam: 1
Employees in R&D: 0
Year of foundation: 2000

Company profile

BioPartner Start-up Ventures is a start-up venture fund established at the end of 2000 by the Ministry of Economics Affairs – Netherlands, aimed at accelerating the Dutch life science industry by improving the entrepreneurial climate for bio-starters and bio-business, and by removing the obstacles identified for bio-entrepreneurs such as, lack of information, financing, laboratory equipment and lab space. It offers stimulation of Life Sciences in the Netherlands and risk capital fund for Life Science start-ups, investing in shares possibly combined with a subordinated loan. One important condition was that private investors must invest an equally large amount in the company. The fund has invested a total amount of 11 Million Euro. The investments were provided in exchange for shares in the start-up company. This initiative resulted in the creation of 46 new life science start-ups in the period 2000-2005. Since then the ongoing participations are managed and sold. The Fund is being managed by the Zernike Group.

Science and Technologies or Services

Life Sciences Investment Fund

Document Actions
Filed under:

Find your life sciences partner in the Amsterdam BioMed Cluster

Find your life sciences partner in the Amsterdam BioMed Cluster

Column

Penny-wise!

Synaps bij column Arjen Brussaard, foto CNCR.nl

By Arjen Brussaard

Recently the topsector plan Life Sciences & Health was published and presented to Minister Verhagen, of the so-called ELI Ministry. The document is an amazing compressed 60-pager, based on months of hard work by the group of experts chaired by Roel Fonville, and summarizes the conclusions after dozens of 1-to-1 meetings, five regional group sessions with dozens of opinion leaders and after having received over 170 (!) memo's, white papers and letters of intent.
More...